Loading

Annals of Aquaculture and Research

Updated of the Pathologies Affecting Cultured Gilthead Seabream, Sparus aurata

Review Article | Open Access

  • 1. Departamento de Microbiología, Universidad de Málaga, Spain
  • 2. Department of Biotechnology & Aquaculture, Instituto de Ciencias Marinas de Andalucía, Spain
+ Show More - Show Less
Corresponding Authors
Carmen Sarasquete, Department of Biotechnology & Aquaculture, Instituto de Ciencias Marinas de Andalucía-ICMAN.CSIC-, 11510-Puerto Real, Cádiz, Spain, Tel: 34-956832612
Abstract

Among other Sparidae species, the gilthead seabream Sparus aurata is the most important fish species in the Mediterranean aquaculture, achieving good growth performances and progressive increased production. However, health management remains as one of the major concerns of the gilthead seabream culture, because diseases can cause major losses to commercial crops. In suboptimal conditions of intensive rearing systems, the danger of disease outbreaks is always present. Since quarantine restrictions were rarely adopted, several microbial pathogens have been transmitted to other geographic locations, and frequently they have colonized new fish hosts and/or new environments. In this work, we have updated some of the most important and also serious pathologies and diseases that from many years ago and presently affect to reared gilthead seabream specimens, mainly those with uncertain or complex aetiology (genetic, nutritional, zootechnic, among others), such as malformations-vertebral deformities, as well as those more classical and emergent parasitic and infectious pathologies and diseases. In addition, avalaible treatment and/or prophylactic measures are also discussed.

Citation

Borrego JJ, Labella AM, Castro D, Ortiz-Delgado JB, Sarasquete C (2017) Updated of the Pathologies Affecting Cultured Gilthead Seabream, Sparus aurata. Ann Aquac Res 4(2): 1033.

Keywords

•    Gilthead seabream
•    Aquaculture
•    Pathologies
•    Diseases
•    Infectious agents
•    Skeletal disorders
•    Malformational alterations

INTRODUCTION

Gilthead seabream (Sparus aurata), a member of the family Sparidae, is found in the Mediterranean Sea and extends into the Atlantic Ocean from the British Isles south to Senegal. Most countries around the Mediterranean culture gilthead seabream; Greece, Turkey, and Spain are the major producers in the region, accounting for over 70% of total production. The culturing of S. aurata has achieved impressive strides in much less than two decades, going from an estimated 110 Tm of fish in 1985 to more than 173,000 Tm in 2013 [1,2]. This success is the result of strong research and development programs in many of the countries, in conjuction with a persistently strong market demand for this fish species. However, the rapid development of gilthead seabream farming has not been paralleled by adequate progress in the veterinary aspects of its culture.

Fish diseases are a primary constraint to the culture of many aquatic species, avoiding both economic and social development in producer countries. This situation can be attributed to a variety of interconnected factors such as, the increased globalization of trade in live aquatic animals and their products; the intensification of aquaculture through the translocation of broodstock, postlarvae, fry and fingerlings; and the development and expansion of the ornamental fish trade to name a few [3]. An adequate aquaculture practice must also consider other matters that are not directly related to fish health because public concerns have a significant influence on how and where fish are cultured. Thus, the environmental impacts of the culture operation, the safety of cutured product for human consumption, and the fish welfare are other important factors taking into account to achieve a sustainable practice of the aquaculture [4].

Most of the diseases that cause serious problems in cultured fish are provoked by exotic pathogens; that is, they were inadvertently introduced into a region via infected fish from another geographic area. Thus, an effective biosecurity programme is vital to maintaining healthy animals and to reduce the risk of adquiring disease in a fish facility. Biosecurity refers to the implementation of methods to prevent the spread of infectious diseases within a farm, and to avoid their transmission to wild fish populations or to adjacent fish farms. Key methods used to maintain biosecurity are pathogen inactivation strategies and avoiding fish-to-fish transmission by mean of geographic isolation of affected farms, separation of diseased fish, specificpathogen-free stocks, and quarantine measures [5].

In order to minimize the risks of pathogens/diseases associated with aquatic animal movements, there are a number of existing global instruments, agreements, codes of practice and guidelines (International Codes) that, if implemented, provide certain levels of protection. Some of the provisions in the current international protocols are not always practically applicable to the diseases of concern to a specific region. Therefore, a regionally adopted health management programme is considered a practical approach. Subasinghe et al. [6], recommended that development of standardized methods for disease diagnosis and screening of pathogens, along with regular evaluation of their effectiveness as compared with other diagnostic methods should be a priority task. Vaccination is another established, proven and cost-effective method for controlling certain infectious diseases in cultured marine animals. Vaccines decrease the severity of disease losses, reduce the need for antibiotic use, leave no residues in the product and do not induce pathogen resistance. In conjunction with good health management and good husbandry practices, there is great potential for the use of vaccine technology for specific use in marine aquaculture.

In this work, we have revised the main infectious pathologies affecting to both wild and reared gilthead seabream; and in addition, some pathologies provoked by physiological (i.e. nutritional disorders), not optimal or inadequate rearing or environmental conditions, and potential genetic factors have also been updated. Future perspectives on welfare, treatment and prophylactic measures to improve the Mediterranean aquaculture are also discussed.

Malformational and skeletal disorders

The presence of morphological abnormalities in reared gilthead seabream is an important problem for current aquaculture and it entails significant economic losses. Malformations can affect different aspects of the morphology of the fish such as pigmentation, shape, scales, skeleton and swim bladder. The high incidence of some malformations significantly reduces the market value of the species commercialized as whole fish and implies an additional effort at farms to eliminate abnormal fish [7]. The incidence of vertebral deformities, i.e. opercular anomalies can vary from 6 to 80% [8-14]. These noticeable quantitative variations can be attributed to several different variable zootechnnical conditions, optimization in the rearing procedures and feeding protocols, and the application of genetic improvement programmes (i.e. bloodstock selection and breeding) during the last two decades. Skeletal deformities are the most relevant malformations and they include head and vertebral column anomalies. Lack of operculum and lordosis, scoliosis, kyphosis and vertebral fusions are the most frequent skeletal anomalies in gilthead seabream, particularly in reared fish, but also in wild populations [15]. Similarly, a slight association with inbreeding has been reported on skeleton abnormalities by Astorga et al. [16], and in addition, NegrínBáez et al. [14], reported inheritance of skeletal deformities in gilthead seabream, such as lack of operculum, lordosis and vertebral fusions, among others. Nevertheless, Castro et al. [10], reported only a slight familiar association when comparing seabream specimens lacking operculum, but neither between lordotics nor between normal ones and, they suggested that most phenotypic variation observed for lordosis and lack of operculum in gilthead seabream is due to environmental factors. Therefore, environmental conditions, nutritional imbalances and genetic factors or their interaction, is believed to be on the basis of most skeletal alterations S. aurata specimens [9,10,14,17-23].

Interestingly, by using histological, histochemistry and immunohistochemistry approaches, recently we have been registered two types of opercular anomalies in reared gilthead seabream specimens [13], which were described according to the classification previously reported by Beraldo et al. [24], Type I: the folding of the operculum (opercle and sub-opercle) into the gill chamber, starting at the upper corner of the branchial cleft and extending down to its lower third; and Type II: the partial lack of the operculum (lack of development of the opercle, subopercle, interopercle and preopercle) with a regression of the loose edge extending down to its lower third. The overall incidence of fish with deformed operculum was 6.3%. These opercular abnormalities unilaterally affected both sides of the head: the right (3.3%) and left (3.0%) equally; whereas the bilateral abnormality in the operculum only affected 1.1% of the reared fish. Fish with a severe external body shape deformity showed internal lesions characterised by an accentuated ventral curvature (lordosis) of the vertebral column. The degree of these pathological symptoms varied along the vertebral column axis and mainly affected vertebrae located between the limit of prehaemal and haemal areas of the vertebral column (position 11 to 15 from urostyle upwards). The incidence of fish affected by lordosis was 10.1%. These histological and histopathological disorders indicated that the reduced opercular surface in the Type I deformity in gilthead seabream was mainly due to the folding of the edge of the opercle from the superior corner towards the gill chamber. The conservation of the different opercular bones that compose the operculum suggested an effect of the rearing conditions during sensitive developmental periods, coinciding with the beginning of skeletogenesis of the opercular complex, which is formed by intramembranous ossification from a condensed core of mesenchymal cells [24,25]. Considering that the supportive tissue of the operculum was not yet formed at this early developmental period, mechanical damage (i.e. excessive water movements) could cause this opercular malformation [26]. Nevertheless, in the opercular deformity (Type II) described in gilthead seabream specimens [13], the coalescence between opercular bone areas might have caused semi-rigidity and tissue fusion of the opercular structures, giving the appearance of underdeveloped or incomplete tissue. These opercular disorders might be mechanically induced by forced opercular movements occurring during ventilation or food ingestion processes [26], although the putative involvement of nutritional factors and/or environmental pollutants should not be negleted [7].

The aetiology of vertebral malformations in fish species is complex, multifactorial and still not completely known. Genetic, environmental, zootechnical and nutritional factors have been frequently associated with different or similar vertebral abnormalities in various fish species. Several authors indicated that vertebral deformities might appear during the notochord segmentation and vertebral centrum differentiation processes [22,27]. However, others suggested that these deformities are a consequence of disfunction in collagen metabolism at notochordal and perinotochordal collagen sheets during early development [28]. However, many vertebral deformities may also occur later in ontogeny, for instance during the ongrowing period, at which point they are generally induced by mechanical overloads [29], or by curvature of the vertebral axis [30], or by a combination of both situations [31,32]. According to Ortiz-Delgado et al. [13], in the affected vertebral region of the lordotic gilthead seabream specimens, a change in chondrocyte morphology, from vacuolated to hyper-dense, and an increased calcium deposition were evidenced, suggesting that a metaplastic shift was involved [33]. Furthermore, in these seabream lordotic specimens, a disorganization of the intervertebral region, with a complete loss of notochordal sheath integrity was evidenced. In addition, imbalanced cell cycling (proliferation vs. apoptosis) detected in deformed vertebral centra showing higher cell proliferation activity, which could explain the presence of dense packaged chondrocytes, occupying most of the intervertebral space without vacuolization. Moreover, a higher remodelling process may occur in lordotic specimens, such as was evidenced by using chondrogenic and osteogenic immunomarkers [7,13,34]. In general a preferential accumulation of osteocalcin in compact bone and notochord cells was detected in notochordal tissues of seabream specimens with deformed vertebrae. It is suggested that lordotic vertebrae should be more fragile that those normal fish with non-deformed axial structures.

A new type of vertebral malformation, named haemal vertebral compression and fusion haemal VCF), was described by Lozoides et al. [35]. It consists of deformed cartilaginous neural and haemal processes and the compression and fusion of vertebral bodies, affecting the posterior part of the vertebral column in combination with lordosis. The early anatomical signs of the haemal VCF consist of abnormal centrum mineralization, malformed cartilaginous neural and haemal processes and developing lordotic alterations. The histological examination of the deformed individuals reveals that haemal VCF is preceded by notochord abnormalities. In older animals suggests that haemal VCF is linked to high mortality rates.

Pathologies provoked by parasitic microorganisms

Parasitic diseases, also known as parasitosis, are infectious (or not) diseases caused or transmitted by eukaryotic organisms. Parasites can affect practically all-living organisms; however, many parasitic organisms do not cause diseases. They can induce stress and immunodepression, and as a consequence secondary infections, pathologies and severe disorders diseases, are more frequent in those parasited fish.

The most frequent parasites that affected during the last decade to reared gilthead seabream were Amyloodinium spp., Cryptocarion spp., Ichthyobodo spp. and Trichodina spp. [36,37]. In addition, these parasites are very good indicators of contamination in aquatic ecosystems. In fact, high rates of mortality and infestations about 80% in gilthead seabream specimens reared under highly stressed aquatic ecosystems have been scored, with presence of inorganic and organic contaminants [38]. Amyloodiniosis or “Velvet disease” is one of the most devasting parasitic diseases in temperate mariculture [39,40]. Amyloodinium ocellatum, a dinoflagellate protozooa highly adapted to parasitism, is able to infect different fish species in a wide range of salinities and temperatures (17 to 30º C). Its life cycle has three main phases: a parasitic feeding stage (trophont), an encysted reproductive stage (tomont), and a free-swimming infective stage (dinospore) [41]. Damages of the gill epithelium and osmoregulatory impairment are the likely causes of fish death. The dinospores are susceptible to various chemotherapies [41,42], but trophonts and tomonts are more resistant. Treatment with 100-200 mg/L formalin for 6-9 h detaches trophonts from fish, but as tomonts, they resume division after the removal of formalin [41]. A copper sulfate treatment (0.75 mg/L) for 14 d is also effective, although toxic for juvenile fish [41]. Survivor fish acquire a certain degree of immunity [43].

Cryptocaryon irritans (Class Colpodea) produced the “Marine White Spot disease”, is a ciliate that invades the epithelium of gills, skin, and eyes, compromising the physiological functions of these organs. The clinical signs include pinhead-sized whitish “blisters” on the skin, epithelial hyperplasia, mucus hypersecretion, skin discoloration, corneal cloudiness, and mainly disruption of the gill lamellar structure and severe respiratory distress [40]. In Mediterranean cultures of S. aurata, the ciliate has been reported in Israel, Italy and Spain [44]. The life cycle of this parasite consists of four phases: the first is parasitic (trophont), after 3-7 d of growth, it leaves its host, loses its cilia (protomont), encysts, and starts dividing (tomont), eventually producing up to 200 free-swimming infective organisms (theront). Theronts have a life span of 24 h, but their ability to infect a host decreases rapidly after 6-8 h [45,46]. Studies on vaccination against Cryptocaryon have produced interesting results [47,48], but no commercial vaccines are still available.

Trichodina spp. has been observed often infesting the gills of reared seabream specimens and also in wild and culture sparids in Mediterranean and Atlantic areas [40,49-51]. Brooklynella hostilis is a ciliate easily recognizable by its oval, dorsoventrally flattened shape, by its notched oral area, and by its size [52]. As a gill pathogen, B. hostilis can cause serious skin lesions [4], destroying the tissue surface of the hosts by mean its cytopharyngeal armature, feeding on tissue debris, ingesting blood cells, and causing hemorrhages in the gills [52]. B. hostilis was diagnosed in cagecultured gilthead seabream in the Red Sea [53].

Microsporidiosis is a disease provoked by eukaryotic parasites belonging to the phylum Microsporidia. This phylum includes obligate intracellular parasites that infect a wide range of vertebrate and invertebrate hosts. Microsporidians have evolved an elaborate mechanism for invading animal host cells, but have otherwise greatly reduced biological complexity. Although the taxonomic affiliation of the Microsporidia has long been controversial, they are now known to either fall within the Fungi or to be extremely closely related to the Fungi [54,55]. Economic losses were recorded in aquaculture due to microsporidian infection of fish [55], establishing a complex coexistence with the host, for example, the genus Glugea develops a special type of hypertrophy forming a xenoma, several of which may aggregate into a large pseudotumoral structure, the most adequate treatment is the oral administration of fumagillin [4,55]. In the Mediterranean region, a microsporidian infection was described in juveniles of cultured gilthead seabream in the French coast attributed to Glugea sp. [56]. Abela et al. [57], observed lesions by microsporidian parasites (genus Pleistophora) in the muscle of cultured gilthead seabream juveniles, and xenome-infections in S. aurata provoked by Microsporidium aurata was also reported by Morsy et al. [58], in the Red Sea. Similar cases of microsporidian infections in the musculature of gilthead seabream have been reported in Greece [59], Italy [60], and Spain [40,61].

Piscine apicomplexans, belonging to the classes Coccidea and Haematozoa, can parasitize a broad spectrum of fish cell types in the intestine, swim bladder, liver, spleen, testes, kidney, gills, and blood [62,63]. Since coccidiosis provoked in fish subclinical and/ or chronic diseases, they may have been overlooked. However, haemogregarine-like organisms were observed in gilthead seabream cultured in Israel [64]. Eimeria sparis and Goussia sparis were recorded in the intestine of gilthead seabream in different facilities in Spain, indicating a wide distribution and a potential responsibility in mortalities [49,65,66]. Cryptosporidium molnari is another species described in gilthead seabream, detecting in its gastric epithelia, with a particularly high prevalence in juveniles [67-70]. Affected fish showed abdominal swelling, ascitis, whitish feces, and with necrosis of the gut epithelial lining. In vitro treatment with bronopol (100 mg/L for 30 min) has demonstrated to be effective, killing 50% of theronts and 100% of protomonts [71].

Myxosporeans are endoparasites that either can reside in visceral cavities such as the gall bladder, the swim bladder, and the urinary tract (celozoic species) or can settle as inter- or intracellular parasites in the blood, in muscle, or in connective tissue (histozoic species). The myxozoans are included in three orders Malacovalvulida, Multivalvulida, and Bivalvulida [72]. The main myxozoans that affect to fish specimens are the genera Myxobolus, Ceratomyxa, Enteromyxum and Sphaerospora (Bivalvulida), genus Kudoa (Multivalvulida), and genus Tetracapsuloides (Malacovalvulida) [73,74]. Infected fish do not always display clinical signs; in fact, an important number of myxosporidian parasites coexist with their asymptomatic host without causing obvious damage [75]. Spores typical of the genus Kudoa were found in the viscera of gilthead seabream cultured in the Red Sea [76], but this parasite causes relatively benign infections, one usually limited to a few individuals. However, under some particular stress conditions or when highly pathogenic species (Ceratomyxa shasta, Myxobolus cerebralis, Tetracapsuloides bryosalmonae) are involved, virulence is enhanced and expressed. General clinical signs are often emaciation, swollen abdomen, and gall bladder full of unreleased bile. Most myxozoan infections elicit only moderate host reactions at least during the early stages of infection, although plasmodia with mature spores can later induce considerable inflammation [4]. Enteromyxum leei (formely Myxidium leei) and other enteromyxosporidan parasites are one of the major disease problems in marine aquaculture, since the infection has a chronic course. Affected fish become anorexic and emaciated, and eventually die with a typical “knife edge” body shape and bloated abdomen, and the extensive necrosis of the intestine produces a foul odor. Following the first report and description of E. leei in cultured gilthead seabream from Cyprus [77], the parasite was found associated with morbidity and mortality in Israel [78], Greece [79-81], France [82], Italy [83], Spain [84], and Tunez [37]. In gilthead seabream, the infection shows variable incidence and severity, possibly indicating a genetically based susceptibility to the disease [74], and direct transmission [85]. Other myxosporean parasite, Polysporoplasma sparis, has occasionally been associated with poor growth and chronic mortality, affecting mainly to glomerular capillaries of the kidney (glomerular disease) [86]. It was reported in Spain, in the Adriatic Sea, and in fish farms all over Greece, with high prevalence during the warmest season [81,86-89]. Enterospora nucleophila is a microsporidium responsible for an emaciative syndrome observed in farmed gilthead seabream. The parasite is mainly found in the intestinal mucosa with clinical signs including anorexia, cachexia, and pale internal organs [57]. Several histopathological damages occur in severe infections and this microsporidium is considered a serious emerging threat in gilthead seabream production [61]. According to Martins et al. [90], three applications of formalin solution (10 mL/m3 ) for 15 d were adequate to control the disease caused by the protozoa. Cellular effectors (lymphocytes, granulocytes, phagocytes, nonspecific cytotoxic cells, and rodlet cells), and also humoral factors (lysozyme, peroxidases, antiproteases, complement, and specific antibodies) seem to be the main fish immune components involved in the response against myxosporoses [91].

Class Monogenea is comprised of mostly ectoparasites fluxes, the most frequently encountered worm in mariculture [92]. Flukes either draw or feed off the host tissues, causing irritation, hyperplasia, haemorrhage and anaemia. Furnestinia echeneis is frequently observed on gilthead seabream in the Mediterranean [93], and they are usually presented at the distal extremities of the gill lamellae [94,95]. The rates of infestation are very low, depending on the temperature [96], and the fish appareared to be in good health and no evident symptoms were exhibited [97]. Sparicotyle chrysophrii is other common monogenean parasite for cultured gilthead seabream [92,94,98], and its haematophagus activity produce severe anaemic conditions in the cold seasons [97]. Gyrodactylus was found on the fins and body surface of gilthead seabream cultured in several Mediterranean regions [40,92]. Other monogenoidean parasites detected in gilthead seabream are the belonging to the species Encotyllabe vallei, Lamellodiscus echeneis, L. ignoratus, and Polylabris tubicirrus [92]. A 1-h formalin treatment (150-200 mg/L) or hydrogen peroxide (200 mg/L, 30 min) are good methods of treatment. Eggs, however, may survive the therapies, so that repeated treatments may be required to disrupt these parasites. Neobenedenia melleni is very sensitive to freshwater and, a 3-min freshwater dip is normally sufficient to free the fish from this infestation, but, the eggs may also survive the treatment [40]. Recently, Chagas et al. [99], have described that the supplementation of the diet with mebendazole controls the monogenean infestations in the freshwater fish Colossoma macroporum.

Class Digenea, such as Monorchis monorchis and Telosentis exiquus, comprises endoparasitic platyhelminths that require at least one intermediate host to complete their life cycle. In S. aurata, the parasite Bucephalus minimus has been found as encysted larval or juvenile stages, and as free adults [100], and Neobenedenia melleni has been detected on the body of gilthead seabream cultured in the Red Sea [101]. Acute infections by the cercariae have occasionally been observed due to severe damage in the host tissues during penetration and migration because the active feeding of the monogeneans on mucus and on epithelial cells leads to hemorrhage, inflammation, and the over-production of mucus [102,103]. Parasites often settle on or around the eyes, damaging the cornea and causing blindness [103,104]. Once encysted, metacercariae do not produce further tissue damage, except intense melanization reaction around the cyst. Cardicola aurata were reported affected gilthead seabream in Spain, Italy, Croatia, and Greece [60,105]. Massive presence of eggs and miracidia caused clogging of the gill capillaries and severe local tissue damage, while the adult individuals could be found in the vessels of the renal parenchyma or in the afferent vessel of single gill arches [106,107].

A large number of copepods belonging to the families Caligidae and Ergasilidae parasitize the itegument of fish [108]. Gill filaments can be severely damaged and skin haemorrhages typically occurring in heavily infestations, although copepod presence on S. aurata has only rarely been associated with fish mortalities [97]. Several treatment agents have been suggested for control of copepods, including formaldehyde, organophosphate insecticides, hydrogen peroxide, ivermectin, pyrethrum, carbaryl, diflubenzuron, to name a few. However, the therapeutic dosage may be toxic for the hosts, and other measures, such as exposures to freshwater, are applied. Family Cymothoidae constitutes the great majority of isopod parasites in fish [109]. These parasitic isopods are grossly visible on skin, mouth and gills of the infected fish, causing considerable damages [110]. In addition, S. aurata is susceptible to the larvae of the Gnathiidae family, of which Gnathia piscivora constitutes a potentially dangerous risk [111]. The most common isopod affecting gilthead seabream in the Mediterranean are Ceratothoa paralella [112] and C. oestroides [113,114].

Bacterial, viral, and fungi pathologies

Vibrio spp. has been isolated frequently from diseased gilthead seabream in several farms around the Mediterranean basin [115]. Mortalities of cultured gilthead seabream were associated with V. alginolyticus, V. parahaemolyticus, V. vulnificus, V. harveyi, V. ordalii, V. salmonicida, and V. anguillarum [40,116- 121]. Vibriosis is characterized by a systemic hemorrhagic septicemia. Lethargy, skin darkening, exophthalmia, anemic gills, petechia on the skin and the base of the fins, and inflammation and ulcers are the typical external signs. Internally, congested visceral blood vessels, intestinal hemorrhages, and accumulation of ascitis fluid in the abdominal cavity are the most common signs of vibriosis [122,123]. Vibrio spp. produces a wide variety of proteases, hemolysins, and other extracellular enzymes that are responsible for the extensive tissue damage [124]. In advanced cases, congestion and liquefaction of the spleen, liver, and kidney can also be observed. Factors such as transport stress, water temperature changes, handling, and low oxygen induced vibriosis in S. aurata [125]. Treatment of vibriosis with medicated feed can be effective if done at the initial stage of the disease, while the fish are still eating. Flumequine, oxytetracyclines, sulfonamides (+ trimethoprim) and florfenicol are the main antimicrobials used for vibriosis treatment. Vaccination as preventive measure is the best option since its effectiveness has been demonstrated about 100% during the protection period using both immersion and injection procedures. Oral formulations with good effectiveness are strongly required by the industry because could help reducing handling and improving welfare, but they are not enough developed. Good animal husbandry and adequate nutrition are essential to prevent the development of the disease and, subsequently, the use of antibiotics. Combination of the suitable and available vaccination protocols has a real benefit in costeffect balance. The emerging crisis of resistance to antibiotics has led to sporadic application of probiotics in S. aurata culture [126], in order to develop immunocompetance in fish to combat with bacterial diseases and also inhibit the colonization of potential pathogens in the digestive tract through competition exclusion principle. However, in general probiotics are low immunogenic in nature, temperature- and salinity-sensitive and cumbersome in application. Phage therapy can be described as the use of bacteriophages to control specific pathogenic or problematic bacteria. Experimental results with marine animal models have demonstrated the efficacy of phage therapy against infectious diseases caused by Vibrio harveyi, V. parahaeamolyticus, V. anguillarum, and V. alginolyticus [127-130].

Photobacteriosis is provoked by two subspecies of Photobacterium damselae, one of them P. damselae sub sp. piscicida caused the “pseudotuberculosis” that is recognized as granulomatous-like lesions in the spleen and kidney of affected fish. This disease develops rapidly into an acute septicemic condition characterized by conspicuous splenomegaly, and high mortalities have been observed in gilthead seabream from Atlantic and Mediterranean areas [118,131-135]. Transmission of the pathogenic bacteria can be vertical, through the gonadal fluids, as well as horizontal through the water route, by this route the bacteria is able to infect its host through the gills, the digestive system and the skin [131,136]. The other subspecies of P. damselae is P. damselae subsp. damselae (formerly Vibrio damsela or Listonella damsela). This microorganism causes skin ulcers or systemic disease in a wide range of fish, including gilthead seabream [137-140], and can also cause skin ulcers in humans [141]. Antibiotics have been the first line of defense in fish aquaculture to control photobacteriosis outbreaks, but after only a few years the pathogens acquired resistance to various antibiotics, such as kanamycin, sulphonamide, tetracycline, ampicillin, chloramphenicol, florfenicol, and erythromycin [142]. Efforts have been focused on gaining a better understanding of the biology of these pathogenic microorganisms with the aim of developing effective vaccination strategies to control the disease. Conventional vaccinology has thus far yielded unsatisfactory results, and recombinant technology has been applied to identify new antigen candidates for the development of subunit vaccines [142].

Pseudomonas anguilliseptica infections have been described in gilthead seabream [143] associated with a hemorrhagic septicaemia named “winter syndrome” or “winter disease” (WD) [40] in the Mediterranean areas. WD refers to a condition exclusively affecting gilthead seabream reared at low temperatures. The disease is considered as a multifactorial problem brought about by the physiological, metabolic, and immunological disturbances associated with the poor tolerance of this species to rearing conditions at temperatures below 15º C [144-148]. Although the WD is probably multifactorial with unresolved aspects of its etiology, the recurrent isolation of P.anguilliseptica of WD-afeccted fish indicates a significant role of this microorganism in the disease [143,149,150]. External signs included a moderate abdominal distension and keratitis, anemia, lethargy and fish become darker and with the typical stress bands, and sometimes petechial haemorrhages on skin [143]. Internally, hepatic pallor and severe distension of the intestines are evident; usually the diseased fish develop meningoencephalitis. The fish mortality of this disease is higher in the second stage (early spring at 15-16º C), where P. anguilliseptica is recorded frequently [143,149,150]. Treatment with ciprofloxacin, erythromycin, gentamycin, oxytetracycline, tetracycline, streptomycin or trimethoprim-sulphamethoxazole gives a good response [151- 153]. Recently, Phumkhachorn & Rattanachaikunsopon [154] used a bath treatment with extract of the plant Cassia alata to control the P. anguilliseptica infection. There are no commercial vaccines available for this disease agent, although several experimental vaccines have been tested [151,155,156].

Tenacibaculum maritimum [157] is a bacterium commonly found in seawater and formerly known as Cytophaga marina or Flexibacter marinus or F. maritimus. It is an opportunistic pathogen responsible for “flexibacteriosis,” also known as “gliding bacterial disease,” “eroded mouth syndrome,” and “black patch necrosis.” Flexibacteriosis was described in Europe, USA, and Japan affecting mainly to larval or juvenile of a high variety of fish species. An increase in water temperature, various stressors and skin abrasions may trigger the development of the disease. The mouth appears eroded and hemorrhagic, lesions may open in the skin, fins and tail appear frayed, and foci of gill rot may develop followed rough handling during grading and other netting procedures in nurseries [40]. The disease can become systemic, involving different internal organs. T. maritimum has been described in gilthead seabream associated with coinfection with monogenean gill parasites (Sparicotyle and Furnestinia) [158,159]. In vitro studies on the susceptibility of T. maritimum to various chemotherapeutic agents indicate that all bacterial strains isolated from different sources exhibit a similar pattern [158], but field results were not always similar [160]. The administration of amoxycillin and trimethoprim and enrofloxacine are effective antimicrobial therapies against this pathogen in field trials [158,161]. An alternative to drugs would be the use of surface-acting disinfectants administered by immersion, such as formalin, potassium permanganate, and hydrogen peroxide [158]. Modifying husbandry parameters (temperature and/or salinity, controlling fish densities, reducing stress conditions, and avoiding overfeeding) decrease the occurrence of tencibaculosis in fish farms [158,162]. To date, there is a general agreement that a vaccine would considerably help to control tenacibaculosis and several research programs have been established [163], although at present, only one bacterin is commercially available to prevent turbot mortalities caused by T. maritimum, but may not be effective in preventing the tenacibaculosis in other fish species [164]. Other vaccine developments are under trial experimentations yet [155,165].

Epitheliocystis is an infectious disease caused by the obligate intracellular bacteria Chlamydia, and it was described in cultured gilthead seabream in Israel [166,167], in Italy [168], and in Spain [94,169]. Co-infections with other fish pathogens, such as monogeneans, Trichodina and Vibrio spp. have been reported by several authors [50,169]. Nevertheless, recently similar epitheliocystis disease that affected to gilthead seabream specimens was associated with intracellular beta-proteobacteria agents, such as Ichthyocystis hellenicum and I. sparus [170]. Epthyteliocystis appears to be a seasonal disease in Mediterranean farmed gilthead seabream, occurring during the warmer months and when juveniles are first introduced into seacages. However, epitheliocystis outbreaks have occurred in aquaculture systems associated with high stocking densities, presence of nutrients, season, temperature and fish age [171]. Since more than one organism might be involved in an outbreak and since diagnosis can be problematic, there is no established treatment for this pathology. Alternative husbandry methods, such as decreasing stress factors and increasing water quality, around the time of outbreaks times has been recommended [172], together with ultraviolet irradiation of water supplies [173]. Antimicrobial therapy has been attempted in control of this microbial pathogen, using tetracycline and macrolide antimicrobials [174]. However, Somridhivej et al. [175], demonstrated that water exchange was the most appropriate treatment to treat the disease or mitigate the heavy infection.

Lymphocystis disease (LCD) is a well-known fish viral infection provoked by a DNA virus (LCDV) belonging to the Iridoviridae family [176], which is characterized by hypertrophy of fibroblastic cells in the dermis connective tissue of affected fish, occasionally proliferating as true epithelial tumours [177]. This viral disease affects a wide variety of fish species, including S. aurata. Paperna et al. [178], reported for the first time the occurrence of LCD in gilthead seabream reared in the red Sea, but imported as fingerlings from Mediterranean Sea. Later, this viral disease was disseminated to several aquaculture nurseries around Mediterranean basin, where the virus probably become endemic, including Italy, Spain, Greece, Turkey, France, and Portugal [179-186]. Although this disease is rarely fatal, fish showing the characteristic symptoms cannot be commercialized, causing important economic losses [179]. The main characteristic of LCD is the appearance of small cream-coloured nodular lesions on the fish skin and fins [187,188]. Each nodule consists of an LCDV-infected cell, named lymphocyst or lymphocystis cell, of up to 1 mm in diameter [178]. These hypertrophied cells may occur singly or grouped in raspberry-like clusters of tumour appearance. These cellular aggregates are usually whitish in colour, and in heavily affected fish, lymphocysts may cover the entire body, spreading from the gills to the fins [178,182,189,190]. Less frequently, they have also been described on eyes, causing exophthalmia, and internally over the mesenteries, peritoneum and several internal organs [187,190,191]. LCD is a chronic and self-limiting disease that, depending on the host fish species and environmental conditions, may persist for a variable period of time [192]. Thus, the LCD-associated lesions may be evident for 1 year in cold-water fish, whereas they disappear after several weeks in warm-water species [178,193]. There is no effective therapy for LCD; reduction in stocking density and the removal of heavily infected individuals are the only measures that can be adopted to reduce the impact of this disease [194]. The maintaining LCDV-free populations should be prioritizied for sustainable aquaculture in endemic areas [195]. Vaccine against LCDV has focused on the development of a recombinant plasmid DNA vaccine with a fragment of the major capsid protein into an expression vector [196], the plasmid is expressed in fish and induced a specific immune response [197-199]. Another experimental vaccine using encapsulated microspheres loaded with pDNA coded for LCDV showed efficacy after oral administration [200].

The Viral Nervous Necrosis (VNN) or Viral Encephalopathy and Retinopathy (VER) is a viral fish disease provoked by the Nervous Necrosis Virus (NNV) belonging to the family Betanodaviridae. Pathogenesis of VER is related to the neuroinvasive nature of the virus and its deleterious effect on tissues in the brain and retina. Clinically, VER is characterized by nervous symptoms, such as impaired coordination, loss of balance, whirling swimming, blindness with consequent changes in pigmentation, swim-bladder hyperinflation, and hyperexcitability in response to noise and light. Other general signs are lack of appetite, lethargy, and anemia. Mortality may reach 100%, in particular in larval and juvenile stages, within 1 week from the onset of the neurological symptoms, depending also on the viral genotype. Chronic, asymptomatic infection of VER is also frequent in older individuals, and it is transmitted both vertically and horizontally routes. NNV has been detected from gilthead seabream farmed in Greece, France and Spain, [140,201-205]. Although, S aurata harbours the virus and acts as an asymptomatic carrier [206], recently it has described the disease affects to this fish species [207,208]. No chemotherapy is available for VER, therefore control depends upon husbandry practices that prevent contact between naïve and infected fish within farms and also between different geographical areas. Ozone has been used to avoid or reduce virus contamination on egg shell surface [209], and virus contaminated water may be effectively sterilised by UV exposure [210]. Different studies have shown that immunisation using recombinant viral coat protein expressed in E. coli or virus-like particles expressed in a baculovirus expression system or formalin-inactivated virus may be effective in controlling the disease [211-213]. Yamashita et al. [214], showed that primary infection with an avirulent aquabirnavirus effectively suppressed secondary betanodavirus infection, suggesting the use of the aquabirnavirus as a potential immunomodulator. Recently, several DNA-based vaccines have been developed against NNV [215,216].

Only a few fungic infections have been reported affecting S. aurata farmed in Mediterranean basin [217-219]. Ichthyophonus spp. causes ulcers and granulomatous lesions in internal organs. Lesions are most common in highly vascularized organs (spleen, kidney, heart, and liver), and the infection to have a chronic course, and prevalence seems to increase with host age [220,221]. The potential infection from wild fish species should not be underestimated since any effective treatment has been devised so far [221]. Abdel-Latif et al. [222], reported that the most prevalent fungi detected in cultured S. aurata in Egypt were species of Aspergillus, Cladosporium, and Fusarium.

FUTURE PERSPECTIVES

Diseases have proved major constraints to efficient production in intensive culture of gilthead seabream in Mediterranean areas. Major improvements in the understanding of the aetiology and epidemiology of this fish species pathologies have been achieved in recent years; and, therefore, fish farmers in several Mediterranean countries have significativelly improved their husbandry practices with greater focus now on fish welfare. Control of many serious infectious diseases has been achieved through new chemicals and vaccines, and this is especially true for bacterial diseases. However, new pathologic problems are emerging, and previously rare diseases becoming much more prevalent; therefore, continued vigilance and solution development is required.

Due to the complex set of interactions that facilitate the spread of disease, multi-level interventions are necessary. Farm-level disease interventions, such as timely diagnosis and treatment, could address the host-pathogen relationship, while improved farm management may address environment-pathogen and environment-host issues. To address disease transmission between farms, regional and national policies, surveillance, reporting, training, and emergency response capabilities are also needed.

Developing and promoting production methods that reduce or eliminate the need for antibiotics, pesticides, and other chemicals, which can have wide-ranging impacts on human, fish, and environmental homeostasis is a need for a sustainable practice of aquaculture. For this, viral vaccines, based on the recombinant DNA technology and subsequently direct DNA vaccination, appear to be very promising. As this involves a transfer of genes, there are significant issues of safety and consumer acceptance to be addressed. Another approach showing promise is the use of proteomics and epitope mapping for the identification of vaccine antigens and the subsequent development of peptide vaccines, which might be appropriate against parasitic diseases. Further methods include the use of virus-like particles or recombinant viral proteins produced in yeast will potentially be use to pathogen control.

New therapies using genomic tools appear to be promised, for example using dsRNA for disease protection and RNA-i-based gene therapies. Antimicrobial peptides are also being studied as a potential therapeutant. Aquaculture diets are also under scrutiny with respect to potential for delivery of immunostimulants and better understanding of interactions between gut microbiota, pathogens and micronutrients, including probiotic effects.

In short, this review has shown that there is a substantial scientific and empirical base for the implementation of Integrated Pathogens Management Strategies (IPMS) in S. aurata farming, and that nowadays integration of all the available preventive and treatment strategies is indispensable to fighting the diseases of this fish species.

REFERENCES

1. Colloca F, Cerasi S. FAO Fisheries and Aquaculture Department. Rome. Updated 8 February. 2005.

2. FAO/STAT. Yearbooks of Fisheries and Aquaculture Statistics. Food and Agriculture Organization of the United Nations, Rome, Italy. 2015.

3. Subasinghe RP, Bondad-Reantaso MG, McGladdery SE. Aquaculture development, health and wealth. In: Aquaculture in the Third Millenium. Technical Proceedings of the Conference on Aquaculture (Subasinghe RP, Bueno P, Phillips MJ, Hough C, McGladdery SE, Arthur JR, eds.). Third Millenium, Bangkok, Thailand. 2001.

4. Noga EJ. Fish Diseases: Diagnosis and Treatment, 2nd Wiley-Blackwell, Ames, USA. 2010.

5. Bondad-Reantaso MG, Subasinghe RP, Arthur JR, Ogawa K, Chinabut S, Adlard R, et al. Disease and health management in Asian aquaculture. Vet Parasitol. 2005; 132: 249-272.

6. Subasinghe RP, McGladdery SE, Hill BJ. (eds.). Surveillance and zoning for aquatic animal diseases. FAO Fish. Tech. Paper No. 451. FAO, Rome, Italy. 2004.

7. Boglione C, Gavaia P, Koumoundouros G, Gisbert E, Moren M, Fontagne S, et al. Skeletal anomalies in reared European fish larvae and juveniles. Part 1: normal and anomalous skeletogenic processes. Rev Aquacult. 2013; 5: S99-S120.

8. Paperna I. Swimbladder and skeletal deformations in hatchery bred Sparus aurata. J Fish Biol. 1978; 12: 109-114.

9. Andrades JA, Becerra J, Fernandez-Llebrez P. Skeletal deformities in larval, juvenile and adult stages of cultured gilthead sea bream (Sparus aurata L.). Aquaculture. 1996; 141: 1-11.

10. Castro J, Pino-Querido A, Hermida M, Chavarrías D, Romero R, GarcíaCortés LA, et al. Heritability of skeleton abnormalities (lordosis, lack of operculum) in gilthead sea bream (Sparus aurata) supported by microsatellite family data. Aquaculture. 2008; 279: 18-22.

11. Koumoundouros G. Morpho-anatomical abnormalities in Mediterranean marine aquaculture. In: Recent Advances in Aquaculture Research (Koumoundouros G, ed.). Transworld Research Network, Kerala, India. 2010; 125-148.

12. Prestinicola L, Boglione C, Makridis P, Spanò A, Rimatori V, Palamara E, et al. Environmental conditioning of skeletal anomalies typology and frequency in gilthead sea bream (Sparus aurata L., 1758) juveniles. PlosOne. 2013; 8: e55736.

13. Ortiz-Delgado JB, Fernández I, Sarasquete C, Gisbert E. Normal and histopathological organization of the opercular bone and vertebrae in gilthead sea bream Sparus aurata. Aquat Biol. 2014; 21: 67-84.

14. Negrin-Baez D, Navarro A, Lee-Montero I, Soula M, Afonso JM, Zamorano MJ. Inheritance of skeletal deformities in gilthead sea bream (Sparus aurata) – lack of operculum, lordosis, vertebral fusion and LSK complex. J Anim Sci. 2015; 93: 53-61.

15. Afonso JM, Montero D, Robaina L, Astorga N, Izquierdo MS, Gines R. Association of a lordosis-scoliosis-kyphosis deformity in gilthead sea bream (Sparus aurata) with family structure. Fish Physiol Biochem. 2000; 22: 159-163.

16. Astorga N, Valencia A, Fenández-Palacios H, Montero D, Zamorano MJ, Aguilera C, et al. Genetic effect of the type of cross and consanguinity level in spawning quality of gilthead sea bream (Sparus aurata L.). Genet Aquaculture. 2003; VIII: 86.

17. Koumoundouros G, Gagliardi F, Divanach P, Boglione C, Cataudella S, Kentouri M. Normal and abnormal osteological development of caudal fin in Sparus aurata L. fry. Aquaculture. 1997; 149: 215-226.

18. Faustino M, Power DM. Development of osteological structures in the sea bream: vertebral column and caudal fin complex. J Fish Biol. 1998; 52: 11-22.

19. Sfakianakis DG, Koumoundouros G, Divanach P, Kentouri M. Osteological development of the vertebral column and of the fins in Pagellus erythrinus (L. 1758). Temperature effect on the developmental plasticity and morpho-anatomical abnormalities. Aquaculture. 2004; 232: 407-424.

20. Sfakianakis DG, Georgakopoulou E, Papadakis IE, Divanach P, Kentouri M, Koumoundouros G. Environmental determinants of haemal lordosis in European sea bass, Dicentrarchus labrax (Linnaeus, 1758). Aquaculture. 2006; 254: 54-64.

21. Afonso JM, Roo FJ. Anomalías morfológicas en peces cultivados: heredabilidad y selección. In: Genética y Genómica en Acuicultura (Martínez P, Figueras A, eds.). Publicaciones Consejo Superior de Investigaciones Científicas, Madrid. 2007; 213-240.

22. Fernandez I, Hontoria F, Ortiz-Delgado JB, Kotzamanis Y, Estevez A, Zambonino-Infante JL, et al. Larval performance and skeletal deformities in farmed gilthead sea bream (Sparus aurata) fed with graded levels of Vitamin A enriched rotifers (Brachionus plicatilis). Aquaculture. 2008; 283: 102-115.

23. Negrin-Baez D, Navarro A, Rodriguez-Ramilo ST, Afonso JM, Zamorano MJ. Identification of quantitative trait loci associated with the skeletal deformity LSK complex in gilthead sea bream (Sparus aurata L). Mar Biotecnol. 2016; 18: 98-106.

24. Beraldo P, Pinosa M, Tibaldi E, Canavese B. Abnormalities of the operculum in gilthead sea bream (Sparus aurata): morphological description. Aquaculture. 2003; 220: 89-99.

25. Koumoundouros G, Oran G, Divanach P, Stefanakis S, Kentouri M. The opercular complex deformity in intensive gilthead sea bream (Sparus aurata L.) larviculture. Moment of apparition and description. Aquaculture. 1997; 156: 165-177.

26. Galeotti M, Beraldo P, de Dominis S, D’Angelo L, Ballestrazzi R, Musetti R, et al. A preliminary histological and ultrastructural study of opercular anomalies in gilthead sea bream larvae (Sparus aurata). Fish Physiol Biochem. 2000; 22: 151-157.

27. Haga Y, Dominique III VJ, Du SJ. Analyzing notochord segmentation and intervertebral disc formation using the twhh:gfp transgenic zebrafish model. Transgenic Res. 2009; 18: 669-683.

28. Santamaría JA, Andrades JA, Herráez P, Fernández-Llebrez P, Becerra J. Perinotochordal connective sheet of gilthead sea bream larvae (Sparus aurata, L.) affected by axial malformations: An histochemical and immunocytochemical study. Anat Rec. 1994; 240: 248-254.

29. Kranenbarg S, Waarsing JH, Muller M, Weinans H, van Leeuwen JL. Lordotic vertebrae in sea bass (Dicentrarchus labrax L.) are adapted to increased loads. J Biomechanics. 2005; 38: 1239-1246.

30. Gorman KF, Handrigan GR, Jin G, Wallis R, Breden F. Structural and micro-anatomical changes in vertebrae associated with idiopathictype spinal curvature in the curveback guppy model. Scoliosis. 2010; 5: 10.

31. Gavaia PJ, Dinis MT, Cancela ML. Osteological development and abnormalities of the vertebral column and caudal skeleton in larval and juvenile stages of hatchery-reared Senegal sole (Solea senegalensis). Aquaculture. 2002; 211: 305-323.

32. Cardeira J, Bensimon-Brito A, Pousao-Ferreira P, Cancela ML, Gavaia PJ. Lordotic-kyphotic vertebrae develop ectopic cartilage-like tissue in Senegalese sole (Solea senegalensis). J Appl Ichthyol. 2012; 28: 460- 463.

33. Boglione C, Gisbert E, Gavaia P, Witten PE, Moren M, Fontagne S, et al. Skeletal anomalies in reared European fish larvae and juveniles. Part 2: main typologies, occurrences and causative factors. Rev Aquacult. 2013; 5: S121-S167.

34. Fernandez I, Ortiz-Delgado JB, Sarasquete C, Gisbert E. Vitamine A effects on vertebral bone tissue homeostasis in gilthead sea bream (Sparus aurata) juveniles. J Appl Ichthyol. 2012; 28: 419-426.

35. Lozoides M, Georgiau AN, Somarakis S, Witten PE, Koumoundouros G. A new type of lordosis and vertebral body compression in Gilthead sea bream, Sparus aurata L: aetiology, anatomy and consequences for survival. J Fish Dis. 2014; 37: 949-957.

36. Paperna I, Baudin-Laurencin F. Parasitic infections in sea bass, Dicentrarchus labrax and gilthead sea bream Sparus aurata in mariculture facilities in France. Aquaculture. 1979; 16: 173-175.

37. Bahri S. Protozoan and myxozoan infections in wild gilthead sea bream (Sparus aurata L.) from North Lake of Tunis, Tunisia. Acta Parasitol. 2012; 57: 114-121.

38. Sarasquete C, Borrega B, Robles R, Núñez R, Bermúdez L, Ortiz-Delgado JB, et al. Parásitos como bioindicadores de calidad y salud en cultivos semiintensivos en esteros. Diagnosis y prognosis de histopatologías branquiales en dorada, Sparus aurata y lubina, Dicentrarchus labrax. Actas Cong Nac Acuicultura. 2013; 320-323.

39. Barbaro A, Francescon A. Parassitosi da Amyloodinium ocellatum (Dinophycea) su larve di Sparus aurata allevate in un impiante di riproduzione artificiale. Oebalia. 1985; 11: 2.

40. Colorni A, Padros F. Diseases and health management. In: Sparidae: Biology and Aquaculture of Gilthead Sea Bream and other Species (Pavlidis MA, Mylonas CC, eds.). Wiley-Blackwell, Oxford. 2011; 321- 357.

41. Paperna I. Reproduction cycle and tolerance to temperature and salinity of Amyloodinium ocellatum (Brown, 1931) (Dinoflagellida). Annal Parasitol Hum Comp. 1984; 59: 7-30.

42. Lawler AR. Studies on Amyloodinium ocellatum (Dinoflagellata) in Mississippi Sound: natural and experimental hosts. Gulf Res Rep. 1980; 6: 403-413.

43. Cobb CS, Levy MG, Noga EJ. Development of immunity by the tomato clownfish Amphiprion frenatus to the dinoflagellate parasite Amyloodinium ocellatum. J Aquat Anim Hlth. 1998; 10: 259-263.

44. Diamant A, Issar G, Colorni A, Paperna I. A pathogenic Cryptocaryonlike ciliate from the Mediterranean Sea. Bull Eur Assoc Fish Pathol. 1991; 11: 122-124.

45. Yoshinaga T, Dickerson HW. Laboratory propagation of Cryptocaryon irritans Brown, 1951 on saltwater-adapted black mollies Poecilia latipinna. J Aquat Anim Hlth. 1994; 6: 197-201.

46. Diggles BK, Lester RJG. Influence of temperature and host species on the development of Cryptocaryon irritans. J Parasitol. 1996; 82: 45-51.

47. Yambo AV, Song YL. Immunization of grouper, Epinephelus coioides, confers protection against a protozoan parasite, Cryptocaryon irritans. Aquaculture. 2006; 260: 1-9.

48. Bai JS, Xie MQ, Zhu XQ, Dan XM, Li AX. Comparative studies on the immunogenicity of theronts, tomonts and trophonts of Cryptocaryon irritans in grouper. Parasitol Res. 2008; 102: 307-313.

49. Alvarez-Pellitero P, Sitja-Bobadilla A, Franco-Sierra A, Palenzuela O. Protozoan parasites of gilthead sea bream, Sparus aurata L., from different culture systems in Spain. J Fish Dis. 1995; 18: 105-115.

50. Cruz-Silva MP, Freitas MS, Orge ML. Co-infection by monogenetic trematodes of the genus Microcotyle V. Beneden & Hesse 1863, Lamellodiscus ignoratus Palombi, 1943, the protozoan Trichodina sp. Ehrenberg, 1838 and the presence of epitheliocystis, Vibrio alginolyticus and V. vulnificus in cultured sea bream (Sparus aurata L.) in Portugal. Bull Eur Assoc Fish Pathol. 1997; 17: 40-42.

51. Mladineo I. Parasite communities of Adriatic cage-reared fish. Dis Aquat Org. 2005; 64: 77-83.

52. Lom J, Dykova I. Protozoan parasites of fishes. Developments in Aquaculture and Fisheries Science. Elsevier, Amsterdam, Holland. 1992; 26.

53. Diamant A. Brooklynella hostilis (Hartmannulidae), a pathogenic ciliate from the gills of maricultured sea bream. Bull Eur Assoc Fish Pathol. 1998; 18: 33-36.

54. Dykova I. Phylum Microspora. In: Fish Diseases and Disorders, Vol. 1, Protozoan and Metazoan Infections (Woo PTK, ed.), 2nd Ed. CAB International, Wallingford, Oxon, UK. 2006, pp. 205-229.

55. Lom J. Microsporidia. In: Fish Diseases, Vol. 1 (Eiras JC, Segner H, Wahli T, Kapoor BG, eds.). Science Publishers, Enfield, USA. 2008; 351-395.

56. Mathieu-Daude F, Faye N, Coste F, Manier JF, Marques A, Bouix G. Occurrence of a microsporidiosis in marine cultured gilt-head bream from the Languedoc coast: a problem of specificity in the genus Glugea (Protozoa, Microspora). Bull Eur Assoc Fish Pathol. 1992; 12: 67-70.

57. Abela M, Brinch-Iversen J, Tanti J, Le Breton A. Occurrence of a new histozoic microsporidian (Protozoa, Microspora) in cultured gilt head sea bream Sparus aurata L. Bull Eur Assoc Fish Pathol. 1996; 16: 196- 199.

58. Morsy K, Bashtar AR, Abdel-Ghaffar F, Al-Quraishy S. Morphological and phylogenetic description of a new xenoma-inducing microsporidian, Microsporidium aurata nov. sp., parasite of the gilthead sea bream Sparus aurata from the Red Sea. Parasitol Res. 2013; 112: 3905-3915.

59. Athanassopoulou F. A case report of Pleistophora sp. infection in cultured sea bream (Sparus aurata L.) in Greece. Bull Eur Assoc Fish Pathol. 1998; 18: 9-21.

60. Fioravanti M, Caffara M, Florio D, Gustinelli A, Marcer F. A parasitological survey of European sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata) cultured in Italy. Vet Res Comm. 2006; 30: 249-252.

61. Palenzuela O, Redondo MJ, Cali A, Takvorian PM, Alonso-Naveiro M, Alvarez-Pellitero P, et al. A new intranuclear microsporidium, Enterospora nucleophila n. sp., causing an emaciative syndrome in a piscine host (Sparus aurata), prompts the redescription of the family Enterocytozoonidae. Int J Parasitol. 2014; 44: 189-203.

62. Davies AJ, Ball SJ. The biology of fish coccidia. Adv Parasitol. 1993; 32: 294-366.

63. Steinhagen D, Davies AJ. Diseases caused by Apicomplexans. In: Fish Diseases, (Eiras JC, Segner H, Wahli T, Kapoor BG, eds.). Science Publishers, Enfield, USA. 2008; 1: 517-567.

64. Paperna I. Sporozoan infection in cultured Sparus aurata L. and wild Siganus luridus. Annal Parasitol Hum Comp. 1979; 54: 385-392.

65. Alvarez-Pellitero P, Palenzuela O, Sitja-Bobadilla A. Ultrastructure and cytochemistry study of Eimeria sparis (Protozoa: Apicomplexa) stages from the intestine of gilthead sea bream Sparus aurata L. (Pisces: Teleostei). Parasitol Res. 1997; 83: 126-136.

66. Sitja-Bobadilla A, Palenzuela O, Alvarez-Pellitero P. Light microscopic description of Eimeria sparis sp. nov. and Goussia sparis sp. nov. (Protozoa: Apicomplexa) from Sparus aurata L. (Pisces: Teleostei). Parasitol Res. 1996; 82: 323-332.

67. Alvarez-Pellitero P, Sitja-Bobadilla A. Cryptosporidium molnari n. sp. (Apicomplexa: Cryptosporidiidae) infection in two marine fish species, Sparus aurata L. and Dicentrarchus labrax L. Int J Parasitol. 2002; 32: 1007-1021.

68. Sitja-Bobadilla A, Alvarez-Pellitero P. Experimental transmission of Cryptosporidium molnari (Apicomplexa: Coccidia) to gilthead sea bream (Sparus aurata L.) and European sea bass (Dicentrarchus labrax L.). Parasitol Res. 2003; 91: 209-214.

69. Sitja-Bobadilla A, Padros F, Aguilera C, Alvarez-Pellitero P. Epidemiology of Cryptosporidium molnari in Spanish gilthead sea bream (Sparus aurata L.) and European sea bass (Dicentrarchus labrax L.) cultures: from hatchery to market size. Appl Environ Microbiol. 2005; 71: 131-139.

70. Sitja-Bobadilla A, Pujalte MJ, Macian MC, Pascual J, Alvarez-Pellitero P, Garay E. Interactions between bacteria and Cryptosporidium molnari in gilthead sea bream (Sparus aurata) under farm and laboratory conditions. Vet Parasitol. 2006; 142: 248-259.

71. Shinn AP, Picon-Camacho SM, Bron JE, Conway D, Yoon GH, Guo FC, et al. The anti-protozoal activity of bronopol on the key life-stages of Ichthyophthirius multifiliis Fouquet, 1876 (Ciliophora). Vet Parasitol. 2012; 186: 229-236.

72. Goater TM, Goater CP, Esch GW. Parasitism: The Diversity and Ecology of Animal Parasites, 2nd Ed. Cambridge University Park, Cambridge. 2014.

73. Sitja-Bobadilla A, Alvarez-Pellitero P. Sphaerospora (Myxosporea: Bivalvulida) infection in cultured gilt head sea bream, Sparus aurata L.: a preliminary report. J Fish Dis. 1992; 15: 339-343.

74. Palenzuela O. Myxozoan infections in Mediterranean mariculture. Parassitologia. 2006; 48: 27-29.

75. Caffara M, Marcer F, Florio D, Quaglio F, Fioravanti ML. Heart infection due to Henneguya sp. (Myxozoa, Myxosporea) in gilthead sea bream (Sparus aurata) cultured in Italy. Bull Eur Assoc Fish Pathol. 2003; 23: 108-112.

76. Paperna I. Kudoa infection in the glomeruli, mesentery and peritoneum of cultured Sparus aurata L. J Fish Dis. 1982; 5: 539-543.

77. Diamant A. A new pathogenic histozoic Myxidium (Myxosporea) in cultured gilthead sea bream Sparus aurata L. Bull Eur Assoc Fish Pathol. 1992; 12: 64-66.

78. Diamant A, Lom J, Dykova I. Myxidium leei n. sp., a pathogenic myxosporean of cultured sea bream Sparus aurata. Dis Aquat Org. 1994; 20: 137-141.

79. Le Breton A, Marques A. Occurrence of a histozoic Myxidium infection in two marine cultured species: Puntazzo puntazzo C. and Pagrus major. Bull Eur Assoc Fish Pathol. 1995; 15: 210-212.

80. Athanassopoulou F, Prapas T, Rodger H. Diseases of Puntazzo puntazzo Cuvier in marine aquaculture systems in Greece. J Fish Dis. 1999; 22: 215-218.

81. Rigos G, Christophilogiannis P, Yiagnisi M, Andriopoulou A, Koutsodimou M, Nengas I, et al. Myxosporean infections in Greek mariculture. Aquacult Int. 1999; 7: 361-364.

82. Sakiti N, Tarer V, Jacquemin D, Marques A. Présence en Méditerranée occidentale d’une Mixosporidie histozoique pathogène dans les éelevages du daurade, Sparus aurata. Annal Sci Nat Zool Biol Anim. 1996; 17: 123-127.

83. Fioravanti ML, Caffara M, Florio D, Gustinelli A, Marcer F, Quaglio F. Parasitic diseases of marine fish: epidemiological and sanitary considerations. Parassitologia. 2006; 48: 15-18.

84. Alvarez-Pellitero P, Sitja-Bobadilla A. Pathology of myxosporea in marine fish culture. Dis Aquat Org. 1993; 17: 229-238.

85. Diamant A. Fish-to-fish transmission of a marine myxosporean. Dis Aquat Org. 1997; 30: 99-105.

86. Palenzuela O, Alvarez-Pellitero P, Sitja-Bobadilla A. Glomerular disease associated with Polysporoplasma sparis (Myxozoa) infections in cultured gilt-head sea bream, Sparus aurata L. (Pisces: Teleostei). Parasitology. 1999; 118: 245-256.

87. Sitja-Bobadilla A, Alvarez-Pellitero P. Light and electron microscopic description of Polysporoplasma n.g. (Myxosporea), Polysporoplasma sparis n.s. and Polysporoplasma mugilis n. sp. from Liza aurata L. Eur J Parasitol. 1995; 31: 77-89.

88. Mladineo I. Myxosporidean infections in Adriatic cage-reared fish. Bull Eur Assoc Fish Pathol. 2003; 23: 113-123.

89. Athanassopoulou F. Myxosporean parasites. In: Review of Disease Interactions and Pathogen Exchange Between Farmed and Wild Finfish and Shellfish in Europe (DIPNET) (Raynard R, Wahli T, Vatsos I, Mortensen S, eds.). VESO Publishers, Oslo, Norway. 2007; 287-293.

90. Martins ML, de Souza VN, de Moraes JRE, de Moraes FR. Gill infection of Leporinus macrocephalus (Garavello & Britski, 1988 Osteichthyes: Anostomidae) by Henneguya leporinicola n. sp. (Myxozoa: Myxobolidae). Description, histopathology and treatment. Rev Bras Biol. 1999; 59: 527-534.

91. Sijta-Bobadilla A. Fish immune response to Myxozoan parasites. Parasite. 2008; 15: 420-425.

92. Strona G, Stefani F, Galli P. Monogenoidean parasites of Italian marine fish: An updated checklist. Ital J Zool. 2010; 77: 417-439.

93. Papoutsoglou S, Costello MJ, Stamou E, Tziha G. Environmental conditions at sea-cages, and ectoparasites on farmed European seabass, Dicentrarchus labrax (L.) and gilt-head sea-bream, Sparus aurata L., at two farms in Greece. Aquacult Res. 1996; 27: 25-34.

94. Padros F, Crespo S. Proliferative epitheliocystis associated with monogenean infection in juvenile sea bream Sparus aurata in the North East of Spain. Bull Eur Assoc Fish Pathol. 1995; 15: 42-44.

95. Vagianou SF, Athanassopoulou F, Ragias V. Prevalence and pathology of ectoparasites of Mediterranean fish, reared under three different environmental and aquaculture conditions in Greece. J Hell Vet Med Soc. 2004; 55: 203-216.

96. Antonelli L, Quilichini Y, Marchand B. Sparicotyle chrysophril (Van Beneden and Hesse 1863) (Monogenea: Polypisthocotylea) parasite of cultured Gilthead sea bream Sparus aurata (Linnaeus 1758) (Pisces: Teleostei) from Corsica: ecological and morphological study. Parasitol Res. 2010; 107: 389-398.

97. Schembri, R. Pathological findings in farmed Sparus aurata with special attention to parasites of the gills, fins and skin. Master Thesis, University of Malta. 2015.

98. Sanz F. Mortality of cultured sea bream (Sparus aurata) caused by an infection with a trematode of the genus Microcotyle. Bull Eur Assoc Fish Pathol. 1992; 12: 186-188.

99. Chagas EC, de Araújo LD, Martins ML, Gomes LC, Malta JCO, Varella AB, et al. Mebendazole dietary supplementation controls Monogenoidea (Platyhelminthes: Dactylogyridae) and does not alter the physiology of the freshewater fish Colossoma macroponum (Cuvier 1818). Aquaculture. 2016; 464: 185-189.

100. Bartoli P, Gibson DI. Synopsis of the life cycles of Digenea (Platyhelminthes) from lagoons of the northern coast of the Western Mediterranean. J Nat Hist. 2007; 41: 1553-1570.

101. Colorni A. Hyperparasitism of Amyloodinium ocellatum (Dinoflagellida: Oodinidae) on Neobenedenia melleni (Monogenea: Capsalidae). Dis Aquat Org. 1994; 19: 157-159.

102. Paperna I. Diseases caused by parasites in the aquaculture of warm water fish. Ann Rev Fish Dis. 1991; 1: 155-194.

103. Egusa S. Infectious Diseases of Fish. AA Balkema Publications, Rotterdam, Holland. 1992.

104. Colorni A. Pathobiology of marine organisms cultured in the tropics. In: Tropical Mariculture (De Silva SS, ed.). Academic Press, San Diego, USA. 1998; 209-255.

105. Alvarez-Pellitero P. Report about fish parasitic diseases. In: Etudes et Recherches, Options Mediterranéennes (Alvarez-Pellitero P, Barja JL, Basurco B, Berthe F, Toranzo AE, eds.). CIHEAM/FAO, Zaragoza. Spain. 2004; 103-130.

106. Padros F, Zarza C, Crespo S. Histopathology of cultured sea bream Sparus aurata infected with sanguinicolid trematodes. Dis Aquat Org. 2001; 44: 47-52.

107. Holzer AS, Montero FE, Repulles-Albelda A, Raga JA. Morphological characterisation and phylogenetic positioning of a new sanguinicolid blood fluke, a pathogen in Mediterranean Sparus aurata L. culture. Eur Assoc Fish Pathol, 13th Int Conf Fish Shellfish Dis. Grado, Italy. 2007; 179.

108. Johnson SC, Treasurer JW, Bravo S, Nagasawa K, Kabata Z. A review of impact of parasitic copepods on marine aquaculture. Zool Etud. 2004; 43: 229-243.

109. Athanassopoulou F, Bitchava K, Pappas IS. An overview of the treatments for parasitic diseases in Mediterranean aquaculture. In: The Use of Veterinary Drugs and Vaccines in Mediterranean Aquaculture (Rogers C, Basurco B, eds.). CIHEAM Options Mediterranéennes, Serie A, Zaragoza, Spain. 2009; 65-83.

110. Khalil RH, Saad TT, El-Hamid TMA. Some studies on parasitic infestations in some marine water fish with special reference on isopoda. J Arab Aquacult Soc. 2014; 9: 75-88.

111. Paperna I, Por FD. Preliminary data on the Gnathiidae (Isopoda) of the Northern Red Sea, the Bitter Lakes and the Eastern Mediterranean and the Biology of Gnathia piscivora n. sp. Rapp Comm Int Expl Scient Mer Médit. 1977; 24: 195-197.

112. Papapanagiotou EP, Trilles JP. Cymothoid parasite Ceratothoa parallela inflicts great losses on cultured gilthead sea bream Sparus aurata in Greece. Dis Aquat Org. 2001; 45: 237-239.

113. Sarusic G. Preliminary report of infestation by isopod Ceratothoa oestroides (Risso, 1826), in marine cultured fish. Bull Eur Assoc Fish Pathol. 1999; 19: 110-112.

114. Mladineo I. Life cycle of Ceratothoa oestroides, a cymothoid isopod parasite from sea bass Dicentrarchus labrax and sea bream Sparus aurata. Dis Aquat Org. 2003; 57: 97-101.

115. Balebona MC, Moriñigo MA, Borrego JJ. Role of extracellular products in the pathogenicity of Vibrio strainson cultured gilt-head sea bream (Sparus aurata). Microbiologia SEM. 1995; 11: 439-446.

116. Colorni A, Paperna I, Gordin H. Bacterial infections in gilthead sea bream Sparus aurata cultured at Elat. Aquaculture. 1981; 23: 257- 267.

117. Balebona MC, Andreu MJ, Bordas MA, Zorrilla I, Moriñigo MA, Borrego JJ. Pathogenicity of Vibrio alginolyticus for cultured gilthead sea bream (Sparus aurata L.). Appl Environ. Microbiol. 1998; 64: 4269-4275.

118. Balebona MC, Zorrilla I, Moriñigo MA, Borrego JJ. Survey of bacterial pathogens affecting farmed gilthead sea bream (Sparus aurata L.) in southwestern Spain from 1990 to 1996. Aquaculture. 1998; 166: 19-35.

119. Company R, Sitja-Bobadilla A, Pujalte MJ, Garay E, Alvarez-Pellitero P, Perez-Sanchez J. Bacterial and parasitic pathogens in cultured common dentex, Dentex dentex L. J Fish Dis. 1999; 22: 299-309.

120. Kissil GW, Tandler A, Elizur A, Colorni A, Zohar Y. Gilthead sea bream culture. In: Encyclopedia of Aquaculture (Stickney R, ed.). John Wiley & Sons, Inc., New York. USA. 2000; 408-416.

121. Haldar S, Maharajan A, Chatterjee S, Hunter SA, Chowdhury N, Hinenoya A, et al. Identification of Vibrio harveyi as a causative bacterium for a tail rot disease of sea bream Sparus aurata from research hatchery in Malta. Microbiol Res. 2010; 165: 639-648.

122. Bordas MA, Balebona MC, Zorrilla I, Borrego JJ, Moriñigo MA. Kinetics of adhesion of selected fish-pathogenic Vibrio strains to skin mucus of gilthead sea bream (Sparus aurata L.). Appl Environ. Microbiol. 1996; 62: 3650-3654.

123. Rigos G, Grigorakis K, Nengas I, Christophilogiannis P, Yiagnisi M, Koutsodimou M, et al. Stress-related pathology seems a significant obstacle for the intensive farming of common dentex, Dentex dentex (Linnaeus). Bull Eur Assoc Fish Pathol. 1998; 18: 15-18.

124. Hjeltnes B, Roberts RJ. Vibriosis. In: Bacterial Diseases of Fish (Inglis V, Roberts RJ, Bromage NR, eds.). Halsted Press, New York. USA. 1993; 109-121.

125. Akayh T, Timur G. Vibriosis in gilthead sea bream (Sparus aurata L.) in farms in the Aegean Sea cost of Turkey. Turkish J Fish Aquat Sci. 2002; 2: 89-91.

126. Salinas I, Abelli L, Bertoni F, Picchietti S, Roque A, Furons D, et al. Monospecies and multispecies probiotic formulations produce different systemic and local immunostimulatory effects in the gilthead sea bream (Sparus aurata L.). Fish Shellf Immunol. 2008; 25: 114-123.

127. Vinod MG, Shivu MM, Umesha KR, Rajeeva BC, Krohne G. Isolation of Vibrio harveyi bacteriophage with a potential for biocontrol of luminous vibriosis in hatchery environments. Aquaculture. 2006; 255: 117-124.

128. Pereira C, Silva YS, Santos AL, Cunha A, Gomes NCM, Almeida A. Bacteriophages with potential for inactivation of fish pathogenic bacteria: Survival, host specificity and effect on bacterial community structure. Mar Drugs. 2011; 9: 2236-2237.

129. Silva YL, Costa L, Pereira C, Mateus C, Cunha A, Calado R, et al. Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production. Plos One. 2014; 9: e114197.

130. Kalatzis PG, Bastias R, Kokkari C, Katharios P. Isolation and characterization of two lytic bacteriophages, φSt2 and φGrn1; phage therapy application for biological control of Vibrio alginolyticus in aquaculture live feeds. Plos One. 2016; 11: e0151101.

131. Magariños B, Toranzo AE, Romalde JL. Different susceptibility of gilthead sea bream and turbot to Pasteurella piscicida infection by the water route. Bull Eur Assoc Fish Pathol. 1995; 15: 88-90.

132. Magariños B, Couso N, Noya M, Merino P, Toranzo AE, Lamas J. Effect of temperature on the development of pasteurellosis in carrier gilthead sea bream (Sparus aurata). Aquaculture. 2001; 195: 17-21.

133. Kvitt H, Ucko M, Colorni A, Batargias C, Zlotkin A, Knibb W. Photobacterium damselae ssp. piscicida: detection by direct amplification of 16S rRNA gene sequences and genotypic variation as determined by amplified fragment length polymorphism (AFLP). Dis Aquat Org. 2002; 48: 187-195.

134. Vatsos I. Photobacterium damselae subsp. piscicida. In: Review of Disease Interactions and Pathogen Exchange between Farmed and Wild Finfish and Shellfish in Europe (DIPNET) (Raynard R, Wahli T, Vatsos I, Mortensen S, eds.). VESO Publishers, Oslo, Norway. 2007; 256-259.

135. Essam HM, Abdellrazeq GS, Tayel SI, Torky HA, Fadel AH. Pathogenesis of Photobacterium damselae subspecies infections in sea bass and sea bream. Microb Pathog. 2016; 99: 41-50.

136. Romalde JL, Magariños B, Lores F, Osorio CR, Toranzo AE. Assessment of a magnetic bead-EIA based kit for rapid diagnosis of fish pasteurellosis. J Microbiol Meth. 1999; 38: 147-154.

137. Fouz B, Toranzo AE, Milan M, Amaro C. Evidence that water transmits the disease caused by the fish pathogen Photobacterium damselae subsp. damselae. J Appl Microbiol. 2000; 88: 531-535.

138. Vera P, Navas JI, Fouz B. First isolation of Vibrio damsela from sea bream (Sparus aurata). Bull Eur Assoc Fish Pathol. 1991; 11: 112-113.

139. Labella A, Vida M, Alonso MC, Infante C, Cardenas S, Lopez-Romalde S, et al. First isolation of Photobacterium damselae ssp. damselae from cultured redbanded sea bream, Pagrus auriga Valenciennes, in Spain. J Fish Dis. 2006; 29: 175-179.

140. Garcia-Rosado E, Cano I, Martin-Antonio B, Labella A, Manchado M, Alonso MC, et al. Co-occurrence of viral and bacterial pathogens in disease outbreaks affecting newly cultured sparid fish. Int Microbiol. 2007; 10: 193-199.

141. Love M, Teebken-Fisher D, Hose JE, Farmer III JJ, Hickman FW, Fanning GR. Vibrio damsela, a marine bacterium, causes skin ulcers on the damselfish Chromis punctipinnis. Science. 1981; 214: 1139- 1140.

142. Andreoni F, Magnani M. Photobacteriosis: Prevention and diagnosis. J Immunol Res. 2014.

143. Berthe FCJ, Michel C, Bernardet JF. Identification of Pseudomonas anguilliseptica isolated from several fish species in France. Dis Aquat Org. 1995; 21: 151-155.

144. Bovo G, Borghesan F, Comuzzi M, Ceschia G, Giorgetti G. ‘Winter disease’; in reared sea-bream: preliminary observations. Boll Soc It Patol Ittica. 1995; 17: 2-11.

145. Doimi M. A new winter disease in sea-bream (Sparus aurata): a preliminary report. Bull Eur Assoc Fish Pathol. 1996; 16: 17-18.

146. Padros F, Tort L, Crespo S. Winter disease in the gilthead sea bream Sparus aurata: some evidences of a multifactorial etiology. In: Seabass and sea bream Culture: Problems and Prospects (Chatain B, Saroglia M, Sweetman J, Lavens P, eds.). European Aquaculture Society, Ostende. Sweden. 1996; 305-307.

147. Gallardo MA, Sala-Rabanal M, Ibarz A, Padros F, Blanco J, FernandezBarros J, et al. Functional alterations associated with the ‘winter syndrome’ in gilthead sea bream (Sparus aurata). Aquaculture. 2003; 223: 15-27.

148. Tort L, Rotllant J, Liarte C, Acerete C, Hernandez A, Ceulemans S, et al. Effects of temperature decrease on feeding rates, immune indicators and histopathological changes of gilthead sea bream Sparus aurata fed with an experimental diet. Aquaculture. 2004; 229: 55-65.

149. Domenech A, Fernandez-Garayzabal JF, Lawson P, Garcia JA, Cutuli MT, Blanco M, et al. Winter disease outbreak in sea-bream (Sparus aurata) associated with Pseudomonas anguilliseptica infection. Aquaculture. 1997; 156: 317-326.

150. Domenech A, Fernandez-Garayzabal JF, Garcia JA, Cutuli MT, Blanco M, Gibello A, et al. Association of Pseudomonas anguilliseptica infection with ‘winter disease’ in sea bream, Sparus aurata L. J Fish Dis. 1999; 22: 69-71.

151. Sakr, SFM, Abd el-Rhman, AMM. Contribution on Pseudomonas septicemia caused by Pseudomonas anguilliseptica in cultured Oreochromis niloticus. 8th Int Symp on Tilapia in Aquaculture. 2008; 1177-1196.

152. Vennerström P. Pseudomoniasis (P. anguilliseptica) in farmed fish. ICES Identification Leaflets for Diseases and Parasites of Fish and Shellfish. Leaflet No. 2015; 63.

153. Kholil I, Hossain MM, Neowajh S, Islam S, Kabir M. Comparative efficiency of some commercial antibiotics against Pseudomonas infection in fish. Int J Fish Aquat Stud. 2015; 2: 114-117.

154. Phumkhachorn P, Rattanachaikunsopon P. Use of Cassia alata aqueous extract as a bath treatment to control Pseudomonas anguilliseptica infection in tilapia (Oreochromis niloticus). Arch Biol Sci. 2015; 67: 1165-1172.

155. Romalde JL, Ravelo C, López-Romalde S, Avendaño R, Magariños B, Toranzo AE. Vaccination strategies to prevent emerging diseases for Spanish aquaculture. Dev Biol. 2005; 121: 85-95.

156. Jang YH, Subramanian D, Heo MS. Efficacy of formalin-killed Pseudomonas anguilliseptica vaccine on immune gene expression and protection in farmed olive flounder, Paralichthys olivaceus. Vaccine. 2014; 32: 1808-1813.

157. Sukui M, Nakagawa Y, Harayama S, Yamamoto S. Phylogenetic analysis and taxonomic study of marine Cytophaga-like bacteria: proposal for Tenacibaculum gen. nov. with Tenacibaculum maritimum comb. nov. and Tenacibaculum ovolyticum comb. nov., description of Tenacibaculum mesophilum sp. nov. and Tenacibaculum amylolyticum sp. nov. Int J Syst Evolut Microbiol. 2001; 51: 1639-1652.

158. Avendaño-Herrera R, Toranzo AE, Magariños B. Tenacibaculosis infection in marine fish caused by Tenacibaculum maritimum: a review. Dis Aquat Org. 2006; 71: 255-266.

159. Kolygas MN, Gourzioti E, Vatsos IN, Athanassopoulou F. Identification of Tenacibaculum maritimum strains from marine farmed fish in Greece. Vet Rec. 2012; 170: 623.

160. Cepeda C, Santos Y. First isolation of Flexibacter maritimus from farmed Senegalese sole (Solea senegalensis, Kaup) in Spain. Bull Eur Assoc Fish Pathol. 2002; 22: 388-392.

161. Soltani M, Shanker S, Munday BL. Chemotherapy of Cytophaga/ Flexibacter-like bacteria (CFLB) infections in fish: studies validating clinical efficacies of selected antimicrobials. J Fish Dis. 1995; 18: 555-565.

162. Soltani M, Munday BL, Burke CM. The relative susceptibility of fish to infections by Flexibacter columnaris and Flexibacter maritimus. Aquaculture. 1996; 140: 259-264.

163. Håstein T, Gudding R, Evensen Ø. Bacterial vaccines for fish-an update of the current situation worldwide. In: Progress in Fish Vaccinology. Developments in Biologicals, (Midtlyng PJ, ed.). Karger, Basel, Switzerland. 2005; 121: 55-74.

164. Toranzo AE, Romalde JL, Dopazo CP, Magariños B, Barja JL. Disease trends in the primary marine fish species cultured in Spain: a 20- year study. World Aquacult. 2004; 35: 35-38.

165. Salati F, Cubadda C, Viale I, Kusuda R. Immune response of sea bass Dicentrarchus labrax to Tenacibaculum maritimum antigens. Fish Sci. 2005; 71: 563-567.

166. Paperna I. Epitheliocystis infections in wild and cultured sea bream (Sparus aurata, Sparidae) and grey mullets (Liza ramada, Mugilidae). Aquaculture. 1977; 10: 169-176.

167. Paperna I, Sabnai I, Zachary A. Ultrastructural studies in piscine epitheliocystis: Evidence for a pleomorphic development cycle. J Fish Dis. 1981; 4: 459-472.

168. Ceschia G, Makovec E. Epitheliocystis in sea bream (Sparus aurata) reared in Italy. Boll Soc It Patol Ittica. 1995; 17:18-24.

169. Crespo S, Zarza C, Padros F, Marín de Mateo M. Epitheliocystis agents in sea bream Sparus aurata: morphological evidence for two distinct chlamydia-like developmental cycles. Dis Aquat Org. 1999; 37: 61-72.

170. Seth-Smith HM, Dourala N, Fehr A, Qi W, Katharios P, Ruetten M, et al. Emerging pathogens of gilthead sea bream: characterisation and genomic analysis of novel intracellular β-proteobacteria. ISME J. 2016; 10: 1791-1803.

171. Nowak BF, LaPatra SE. Epitheliocystis in fish. J Fish Dis. 2006; 29: 573-578.

172. Groff J, LaPatra S, Munn R, Anderson M, Osburn B. Epitheliocystis infection in cultured white sturgeon (Acipenser transmontanus): antigenic and ultrastructural similarities of the causative agent to the chlamydiae. J Vet Diagn Invest. 1996; 8: 172-180.

173. Miyaki K, Mizuta K, Yamamoto N, Yoshikoshi K, Kanai K, Tabeta O. Mass mortality of hatchery-reared juveniles of bartail flathead, Platycephalus sp. due to epitheliocystis-like disease. Bull Nagasaki Pref Instit Fish. 1998; 24: 7-10.

174. Goodwin AE, Park E, Nowak BK. Successful treatment of largemouth bass, Micropterus salmoides (L.), with epitheliocystis hyperinfection. J Fish Dis. 2005; 28: 623-625.

175. Somridhivej B, Taveekijakarn P, Meanan C, Somsiri T. Treatment of epitheliocystis in juvenile tilapia. Proc 47th Kasetsart Univ Ann Conf. 2009; 1-8.

176. Borrego JJ, Valverde EJ, Labella AM, Castro D. Lymphocystis disease virus: its importance in aquaculture. Rev Aquacult. 2016. 177. Samalecos CP. Analysis of the structure of fish lymphocystis disease virions from skin tumours of Pleuronectes. Arch Virol. 1986; 91: 1-10.

178. Paperna I, Sabnai I, Colorni A. An outbreak of lymphocystis in Sparus aurata L. in the Gulf of Aqaba, Red Sea. J Fish Dis. 1982; 5: 433-437.

179. Masoero L, Ercolini C, Caggiano M, Rossa A. Osservazioni preliminary sulla linfocisti in una maricoltura intensive italiana. Riv It Piscicolt Ittiopatol. 1986; 21: 70-74.

180. Menezes J, Ramos A, Pereira TG. Lymphocystis disease: an outbreak in Sparus aurata from Ria Formosa, south coast of Portugal. Aquaculture. 1987; 67: 222-225.

181. Moate RM, Harris JE, McMahon S. Lymphocystis infections in cultured gilt-head sea bream (Sparus aurata) in the Aegean Sea. Bull Eur Assoc Fish Pathol. 1992; 12: 134-136.

182. Le Deuff RM, Renault T. Lymphocystis outbreaks in farmed sea bream, Sparus aurata, first report on French Mediterranean coast. Bull Eur Assoc Fish Pathol. 1993; 13: 130-133.

183. Garcia-Rosado E, Castro D, Rodriguez S, Perez-Prieto SI, Borrego JJ. Isolation and characterization of lymphocystis virus (FLDV) from gilt-head sea bream (Sparus aurata, L.) using a new homologous cell line. Bull Eur Assoc Fish Pathol. 1999; 19: 53-56.

184. Bovo G, Florio D. Viral diseases of cultured fish. In: Fish Diseases (Eiras JC, Segner H, Wahli T, Kapoor BG, eds.). Science Publishers, Enfield, USA. 2008; 185-238.

185. Haddad-Boubaker S, Bouzgarou N, Fakhfakh E, Khayech M, Mohamed SB, Megdich A, et al. Detection and genetic characterization of lymphocystis disease virus (LCDV) isolated during disease outbreaks in cultured gilt-head sea bream Sparus aurata in Tunisia. Fish Pathol. 2013; 48: 101-104.

186. Muthuramalingam US, Marudhupandi T, Haq MAB, Thankappan T, Kumar A. Histopathological study of lymphocystis disease virus (LCDV) in cultured false clownfish, Amphiprion ocellaris (Cuvier, 1830) and true clownfish, Amphiprion percula (Lacepede, 1802). J Coast Life Med. 2014; 2: 264-269.

187. Colorni A, Diamant A. Splenic and cardiac lymphocystis in red drum, Sciaenops ocellatus (L.). J Fish Dis. 1995; 18: 467-471.

188. Sarasquete C, Gonzalez de Canales ML, Arellano J, Perez-Prieto SI, Garcia-Rosado E, Borrego JJ. Histochemical study of lymphocystis disease in skin of gilthead sea bream, Sparus aurata, from the South Atlantic coast of Spain. Histol Histopathol. 1998; 13: 37-45.

189. Flügel RH. Lymphocystis disease virus. In: Current Topics in Microbiology and Immunology, (Willis DB, ed.). Springer-Verlag, Berlin. Germany. 1985; 116: 133-150.

190. Xing J, Sheng X, Zhan W. Lymphocystis disease and diagnostic methods in China. Aquacult Asia Magazine. 2006; 11: 30-33.

191. Wolf K. Fish Viruses and Fish Viral Diseases. Cornell University Press, Ithaca. USA. 1988.

192. Williams T. The iridoviruses. Adv Virus Res. 1996; 46: 347-412.

193. Gonzalez de Canales ML, Muñoz-Cueto JA, Arellano J, Garcia-Garcia A, Sarasquete C. Histological and histochemical characteristics of the lymphocystis disease in gilthead sea bream, Sparus aurata, L. from the South-Atlantic coast of Spain. Eur J Histochem. 1996; 40: 143- 152.

194. Hick P, Becker J, Whittington R. Iridoviruses of fish. In: Aquaculture Virology (Kibenge FSB, Godoy MG, eds.). Academic Press, London. UK. 2016; 127-152.

195. Tak Seng I, Colorni A. Infectious diseases of warm water fish in marine and brackish waters. In: Diseases and Disorders of Finfish in Cage Culture (Woo PTK, Bruno DW, Lin LHS, eds.). Cab International, Wallingford, UK. 2002; 193-230.

196. Zheng FR, Sun XQ, Wu X, Liu HZ, Zhang JX. Study on the distribution and expression of a DNA vaccine against lymphocystis disease virus in Japanese flounder (Paralichthys olivaceus). Aquaculture. 2006; 261: 1128-1134.

197. Zheng F, Sun X, Liu H, Wu X, Zhong N, Wang B, et al. Distribution and expression in vitro and in vivo of DNA vaccine against lymphocystis disease virus in Japanese flounder (Paralichthys olivaceus). Chin J Oceanol Limnol. 2010; 28: 67-74.

198. Zheng F, Sun X, Wu X, Liu H, Li J, Wu S, et al. Immune efficacy of a genetically engineered vaccine against Lymphocystis Disease Virus: Analysis of different immunization strategies. Evid Based Complement Alternat Med. 2011; 2011: 729216.

199. Zheng FR, Sun XQ, Xing MQ, Liu H. Immune response of DNA vaccine against lymphocystis disease virus and expression analysis of immune-related genes after vaccination. Aquaculture Res. 2013; 41: 1444-1451.

200. Tian JY, Sun XQ, Chen XG. Formation and oral administration of alginate microspheres loaded with pDNA for lymphocystis disease virus (LCDV) to Japanese flounder. Fish Shellf Immunol. 2008; 24: 592-599.

201. Comps M, Raymond JC. Virus-like particles in the retina of the sea bream, Sparus aurata. Bull Eur Assoc Fish Pathol. 1996; 16: 161-163.

202. Dalla Valle L, Zanella L, Patarnello P, Paolucci L, Belvedere P, Colombo L. Development of a sensitive diagnostic assay for fish nervous necrosis virus based on RT-PCR plus nested PCR. J Fish Dis. 2000; 23: 321-327.

203. Dalla Valle L, Toffolo V, Lamprecht M, Maltese C, Bovo G, Belvedere P, et al. Development of a sensitive and quantitative diagnostic assay for fish nervous necrosis virus based on two-target real-time PCR. Vet Microbiol. 2005; 110: 167-179.

204. Beraldo P, De Nigris G, Rogato F, Galeotti M. Histological and immunohistochemistry findings of viral encephalopathyretinopathy in gilthead sea bream larvae (Sparus aurata, L. 1578) reared in Italy. Eur Assoc Fish Pathol, 13th Int Conf Fish Shellfish Dis. Grado, Italy. 2007; 140.

205. Bitchava K, Xylouri E, Fragkiadaki E, Attanassopoulou F, Attanassopoulou M, Sabatakou O. First incidence of clinical signs of nodavirus infection in sea bream, Sparus auratus L. Isr J Aquacult – Bamidgeh. 2007; 59: 3-9.

206. Castric J, Thiery R, Jeffroy J, de Kinkelin P, Raymond JC. Sea bream Sparus aurata, an asymptomatic contagious fish host for nodavirus. Dis Aquat Org. 2001: 47: 33-38.

207. Cutrin JM, Thiery R, Leao P, Olveira JG, Barja JL, Bandin I. Emergence of pathogenic betanodaviruses belonging to SJNNV genogroup in farmed fish species from the Iberian Peninsula. J Fish Dis. 2007; 30: 225-232.

208. Olveira JG, Souto S, Dopazo CP, Thiery R, Barja JL, Bandin I. Comparative analysis of both genomic segments of betanodaviruses isolated from epizootic outbreaks in farmed fish species provides evidence for genetic reassortment. J Gen Virol. 2009; 90: 2940-2951.

209. Grotmol S, Totland GK. Surface disinfection of Atlantic halibut Hippoglossus hippoglossus eggs with ozonated sea-water inactivates nodavirus and increases survival of the larvae. Dis Aquat Org. 2000; 39: 89-96.

210. Frerichs GN, Tweedie A, Starkey WG, Richards RH. Temperature, pH and electrolyte sensitivity, and heat, UV and disinfectant inactivation of sea bass (Dicentrarchus labrax) neuropathy nodavirus. Aquaculture. 2000; 185: 13-24.

211. Tanaka S, Mori K, Arimoto M, Iwamo T, Nakai T. Protective immunity of seven band grouper, Epinephelus septemfasciatus Thunberg, against experimental viral nervous necrosis. J Fish Dis. 2001; 24: 15-22.

212. Thiery R, Cozien J, Cabon J, Lamour F, Baud M, Schneemann A. Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles. J Virol. 2006; 80: 10201-10207.

213. Yamashita Y, Fujita Y, Kawakami H, Nakai T. The efficacy of inactivated virus vaccine against viral nervous necrosis (VNN). Fish Pathol. 2005; 40: 15-21.

214. Yamashita Y, Mori K, Nakai T. Protection against viral nervous necrosis conferred by simultaneous inoculation of aquabirnavirus and inactivated betanodavirus in sevenband grouper, Epinephelus septemfasciatus (Thunberg). J Fish Dis. 2009; 32: 201-210.

215. Vimal S, Farook MA, Madan N, Abdul Majeed S, Nambi KSN, Taju G, et al. Development, distribution and expression of a DNA vaccine against nodavirus in Asian seabass, Lates calcarifier (Bloch, 1790). Aquac Res. 2014; 47: 1209-1220.

216. Valero Y, Awad E, Buonocore F, Arizcun M, Esteban MA, Meseguer J, et al. An oral chitosan DNA vaccine against nodavirus improves transcription of cell-mediated cytotoxicity and interferon genes in the European sea bass juveniles gut and survival upon infection. Dev Comp Immunol. 2016; 65: 64-72.

217. Athanassopoulou F. Ichthyophoniasis in sea bream, Sparus aurata (L.), and rainbow trout, Oncorhynchus mykiss (Walbaum) from Greece. J Fish Dis. 1992; 15: 437-441.

218. Franco-Sierra A, Sitja-Bobadilla A, Alvarez-Pellitero P. Ichthyophonus infection in cultured marine fish from Spain. J Fish Biol. 1997; 51: 830-839.

219. Giarratana F, Filiciotto F. Grave episodio di ittiofonosi muscolare in Sparus aurata d’allevamento: descrizione di un caso e considerazioni igienistiche. Ittiopatologia. 2007; 4: 41-48.

220. Yanong RP. Fungal diseases of fish. Vet Clin N Am. 2003; 6: 377-400.

221. Elatta MEA. Some bacterial and fungal affections causing disease problems in cultured sea bream Sparus aurata in Damietta Governorate and trials for control. J Arab Aquacult Soc. 2013; 8: 357-372.

222. Abdel-Latif HMR, Khalil RH, El-hofi HR, Saad TT, Zaied SMA. Epidemiological investigations of mycotic infections of cultured gilthead sea bream, Sparus aurata at Marriott Lake, Egypt. Int J Fish Aquat Stud. 2014; 2: 5-13.

Received : 22 Mar 2017
Accepted : 12 Apr 2017
Published : 14 Apr 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X